To BioPorto, openness and transparency are essential in maintaining good relations with investors. BioPorto aims to give the market open, satisfactory information about the company’s operations, strategy and results with a view to ensuring fair pricing of the share and to contribute to ensuring good corporate governance.
All stakeholders should have fast, equal access to important information about BioPorto’s development and growth. One of the ways this is effectuated is by publicizing in-house knowledge in company announcements to Nasdaq Copenhagen, which are subsequently made available at the company’s website, www bioporto.com. Investors and other interested can sign up for notification of published company announcements, newsletters and other material in the investor section of the website (News subscription service). Other publicized information, including general corporate and investor presentations, are made available to the general public at the website, and BioPorto also publishes an investor newsletter for investors and others with an interest in the group, published according to the news flow.
BioPorto uses quiet periods prior to the publication of annual and quarterly reports. In quiet periods no investor meetings are held. Relevant dates for quiet periods are listed in the financial calendar.
To ensure an efficient, expedient dialog with our share holders, BioPorto encourages its share holders to let their share holding be registered and to participate in annual general meetings. The IR Department is also responsible for ensuring that information from the company’s IR stakeholders is passed on to the management and the board of directors.
Gry HUsby Larsen, General Counsel
Peter Mørch Eriksen, CEO
Tel.: +45 4529 0000